Platelet-Derived Exosomes in Aesthetics: Data, Safety, and Real-World Use Cases
Exosomes are having a moment right now, but this is the first time I’ve felt like I was able to sit down and really unpack what matters, the science behind them, the variability in sources, and why not all exosome products are created equal. In our conversation, Alisa Lask, CEO of Rion Aesthetics, helped bring clarity to a field that’s quickly becoming noisy, and I found myself genuinely impressed by the rigor and precision behind the platelet-derived exosomes she describes. For those of us watching regenerative aesthetics evolve, this discussion offers a grounded, thoughtful look at what’s real, what’s emerging, and what clinicians should be paying attention to. I think you’ll find it as illuminating as I did.









